January 9, 2017 / 9:11 PM / 8 months ago

BRIEF-Abiomed announces preliminary q3 preliminary revenue

Jan 10 (Reuters) - Abiomed Inc

* Abiomed announces preliminary q3 fy 2017 revenue of $114.7 million, up 34% over prior year

* Q3 revenue $114.7 million versus i/b/e/s view $113.4 million

* Sees fy 2017 revenue $435 million to $445 million

* Abiomed Inc - is maintaining its fiscal year 2017 revenue guidance of $435 million to $445 million

* Abiomed Inc - also maintaining its fiscal year guidance for gaap operating margin to be in range of 18% to 20%

* Abiomed Inc - qtrly preliminary unaudited u.s. Revenue from impella products grew 34% to approximately $100.3 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below